Ferragamo partnership
This article was originally published in The Rose Sheet
Executive Summary
Italian luxury brand Salvatore Ferragamo has named Selective Beauty its distribution partner for the U.S. market, effective May 1. The decision follows successful agreements between Selective Beauty and the brand in Europe, company adds. Under the deal, Selective Beauty will oversee national distribution for all Ferragamo Parfums and Emanuel Ungaro fragrances at specialty department stores and Ferragamo boutiques. The new agreement marks the end of Ferragamo's previous four-year relationship with American distributor Gary Farn, which the firms jointly agreed to terminate as of April 30, according to the company. In March, Selective Beauty signed a distribution agreement with designer John Galliano (1"The Rose Sheet" March 12, 2007, Marketing in Brief)...
You may also be interested in...
Marketing In Brief
Crest five-minute whitening: Procter & Gamble will support its new five-minute home-use whitening strips, Crest Whitestrips Daily Multicare, with a national ad campaign built around the theme, "The Brightest Five Minutes of Your Day," firm says. The campaign will feature print ads in April books, TV ads breaking March 26, consumer promotion and branded Web sites, among other initiatives, P&G says. Crest Whitestrips Daily Multicare are the first to whiten teeth in five-minute applications by removing surface stains. They also protect teeth from stain buildup, as daily use outpaces the rate of stain formation, not allowing stains time to accumulate, P&G claims. Available now, the strips retail for $39.99 for 42 applications, with each pouch containing one upper and one lower strip...
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.